Further research and trials needed for hand eczema

In a review of the condition and associated drug development opportunities, GlobalData describes chronic hand eczema (CHE) as a persistent, inflammatory skin disorder characterized by redness and itching, significantly reducing quality of life (QoL).

Although multiple treatments for CHE are available, significant unmet need remains in long-term disease management and symptom control unable to be addressed by the current therapies. Therefore, there is a clear demand for therapies that offer sustained relief, fewer side effects, and improved ease of use, GlobalData states.

'Big unmet need'